Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists

Parkinson's Disease and Movement Disorder Center of Boca Raton · 2007
ClinicalTrials.gov · Datasets · License: Public Domain · 2007
Open Source ↗
parkinson-s-disease
parkinson's disease, dopamine agonist adverse effects, mao-b inhibitor, orally disintegrating selegiline, zelapar, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 868815
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.